CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −1,263 | $82.26 | $104K | 2,927,983 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −4,631 | $83.46 | $387K | 2,923,352 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −12,959 | $84.57 | $1.1M | 2,910,393 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −8,408 | $85.01 | $715K | 2,901,985 |
| 2025-06-02 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $13.56 | $68K | 14,009 |
| 2025-06-02 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −4,438 | $77.97 | $346K | 9,751 |
| 2025-06-02 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −562 | $78.65 | $44K | 9,009 |
| 2025-06-02 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +749 | $71.68 | $54K | 9,758 |
| 2025-06-02 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +749 | 10,507 | ||
| 2025-06-02 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 41,571 | ||
| 2025-06-02 | Maduck Sean See Remarks | Grant or award 10b5-1 | +888 | $71.68 | $64K | 16,817 |
| 2025-06-02 | Maduck Sean See Remarks | Grant or award 10b5-1 | +888 | 17,705 | ||
| 2025-06-02 | Maduck Sean See Remarks | Grant or award 10b5-1 | +20,000 | $5.05 | $101K | 37,705 |
| 2025-06-02 | Maduck Sean See Remarks | Sale 10b5-1 | −5,752 | $77.91 | $448K | 31,953 |
| 2025-06-02 | Maduck Sean See Remarks | Sale 10b5-1 | −6,191 | $78.87 | $488K | 25,762 |
| 2025-06-02 | Maduck Sean See Remarks | Sale 10b5-1 | −6,246 | $79.89 | $499K | 19,516 |
| 2025-06-02 | Maduck Sean See Remarks | Sale 10b5-1 | −1,811 | $80.77 | $146K | 17,705 |
| 2025-06-02 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 61,986 | ||
| 2025-06-02 | Robb Gary Charles Chief Business Officer | Grant or award | +997 | $71.68 | $71K | 16,203 |
| 2025-06-02 | Robb Gary Charles Chief Business Officer | Grant or award | +997 | 17,200 |
Page 25 of 61 · 1,220 trades